Stock PAIC PETA ACQU
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News PETA ACQU

Equities

PAIC

US7164211028

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
PETA ACQU : Amendments to Articles of Incorporation/Bylaws/Change in Fiscal Year - Form 8-K
PU
Petra Acquisition, Inc.(NasdaqCM:PAIC) dropped from NASDAQ Composite Index
CI
Revelation Biosciences, Inc. completed the acquisition of Petra Acquisition, Inc. in a reverse merger transaction.
CI
Petra Acquisition : Announces Share Redemption Backstop and Forward Purchase Agreements in Connection with Revelation Biosciences, Inc. Business Combination - Form 8-K
PU
PETRA ACQUISITION INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Petra Acquisition, Inc. Announces Share Redemption Backstop and Forward Purchase Agreements in Connection with Revelation Biosciences, Inc. Business Combination
AQ
PETRA ACQUISITION INC. : Other Events (form 8-K)
AQ
Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.
AQ
Revelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory Board
AQ
Revelation Biosciences Inc. Announces Creation and Appointments to Scientific Advisory Board
AQ
PETRA ACQUISITION INC. : Other Events (form 8-K)
AQ
Revelation Biosciences Inc. Announces Initiation of a Phase 1b Clinical Study of REVTx-99 for the Experimental Treatment of Allergic Rhinitis and Chronic Nasal Congestion
AQ
Revelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, to Optimize Value of the Company’s Diagnostic Tool, REVID™
AQ
PETRA ACQUISITION INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Petra Acquisition, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
PETRA ACQUISITION INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
PETRA ACQUISITION INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Petra Acquisition : Revelation Biosciences Inc. Receives Approval to Begin a Phase 1b Clinical Study of REVTx-99 as an Experimental Treatment for Allergic Rhinitis and Chronic Nasal Congestion
AQ
Petra Acquisition : Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections
AQ
Petra Acquisition : PROMISSORY NOTE (Form 8-K)
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PAIC Stock
  4. News PETA ACQU